DHC vs. FGEN

In the year-to-date period, DHC achieves a -31.67% return, which is significantly higher than FGEN's -62.24% return. Over the past 10 years, DHC has outperformed FGEN with an annualized return of -14.72%, while FGEN has yielded a comparatively lower -34.71% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Diversified Healthcare Trust (DHC) and FibroGen, Inc. (FGEN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current DHC Sharpe Ratio is 0.26, which is higher than the FGEN Sharpe Ratio of -0.22. The chart below compares the historical Sharpe Ratios of DHC and FGEN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

DHC's dividend yield for the trailing twelve months is around 1.59%, while FGEN has not paid dividends to shareholders.

The maximum DHC drawdown since its inception was -96.19%, roughly equal to the maximum FGEN drawdown of -99.56%. Use the drawdown chart below to compare losses from any high point for DHC and FGEN. For additional features, visit the drawdowns tool.

The current volatility for Diversified Healthcare Trust (DHC) is 24.85%, while FibroGen, Inc. (FGEN) has a volatility of 31.27%. This indicates that DHC experiences smaller price fluctuations and is considered to be less risky than FGEN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Diversified Healthcare Trust and FibroGen, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.